JADA (JADA) Stock Price & Analysis
JADA (JADA) rose 0.00% to USD 0 as of July 26, 2026 at 22:48 UTC, according to Nexqual real-time market data.
JADA last closed at USD 0; the session ranged USD 0–0 on volume of 228,857 shares. Market capitalization is $45,998, with a 52-week range of USD 0–0.01 (PNK). Source: Nexqual, July 26, 2026 at 22:48 UTC.
Key Statistics (as of July 26, 2026 at 22:48 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.01 |
| Volume | 228,857 shares |
| Market Cap | $45,998 |
| Exchange | PNK |
Technical Analysis (JADA)
Nexqual's technical model rates JADA "STRONG SELL" based on 0 bullish and 6 bearish signals across 125 daily candles, as of July 26, 2026 at 22:48 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
Analyst Ratings (JADA)
Wall Street analysts rate JADA "None", per Nexqual as of July 26, 2026 at 22:48 UTC.
| Consensus Rating | None |
|---|
Earnings (JADA)
Source: Nexqual, July 26, 2026 at 22:48 UTC.
Financials & Fundamentals (JADA)
| Total Revenue | $18.74M |
|---|---|
| Revenue Growth (YoY) | -78.20% |
| Gross Margin | +77.48% |
| Operating Margin | +23.43% |
| Profit Margin | +45.96% |
| ROE | +10.90% |
| Current Ratio | 11.59 |
| Total Cash | $16.27M |
| Total Debt | $0 |
| Free Cash Flow | $10.74M |
Source: Nexqual, July 26, 2026 at 22:48 UTC.
Financial Health Score (JADA)
Nexqual rates JADA's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 22:48 UTC.
| Growth | Critical — Revenue -78% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Mixed — $16M cash, no debt |
| Cash Flow | Strong — FCF $11M, 57% margin |
| Efficiency | Mixed — ROE 11%, ROA 9.5% |
Ownership (JADA)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 459.98M |
Source: Nexqual, July 26, 2026 at 22:48 UTC.
Leadership (JADA)
JADA is led by Hua-Cai Song (age 62), Chief Executive Officer and Director, per Nexqual as of July 26, 2026 at 22:48 UTC.
| Chief Executive Officer and Director | Hua-Cai Song (age 62) |
|---|---|
| Chief Financial Officer, Principal Accounting Officer and Secretary | Chen-Qing Luo (age 52) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CSGH | CHINA SUN GROUP HIGH-TECH CO | USD 0 | ▲ 0% |
| LTUS | Lotus Pharmaceuticals, Inc. | USD 0 | ▲ 0% |
| PMPG | PREMIER PRODS GROUP INC | USD 0 | ▲ 0% |
| SPOM | SPO Global Inc. | USD 0 | ▲ 0% |
| CHME | China Medicine Corp. | USD 0.02 | ▼ 4.76% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 22:48 UTC. This page is informational and not investment advice.